速递｜司美格鲁肽不是兴奋剂，别听网民造谣了

Core Viewpoint - The 2025 list of prohibited substances has been officially released, including 400 types of drugs, with 9 new additions compared to 2024 [2] Group 1: New Additions to the Prohibited List - The new additions include 2 peptide hormones and 2 stimulants, while other categories have seen various changes [3][4] - The two new peptide hormones are S519 and S597 [6] - The two new stimulants are Midodrine and Tesofensine [7] - Five new drugs have been added under the "Other Drugs" category, including Elagolix and MOTS-c [7] Group 2: Clarification on Semaglutide - Recent claims that Semaglutide is classified as a stimulant are inaccurate, as it is not listed in the 2025 directory [7][8] - Semaglutide is a GLP-1 receptor agonist, and the directory does not include GLP-1 or its analogs [8] - The only related substance in the directory is IGF-1, which is fundamentally different from GLP-1 [8] - Semaglutide remains under monitoring programs to observe its impact on athletes, consistent with 2024 arrangements [8] Group 3: Industry Context - The GLP-1 drugs are a new class of hypoglycemic agents that enhance insulin secretion and suppress appetite, leading to weight loss and blood sugar reduction [15]